Showing results (1761-1770 of 3,794) with videos related to
Sort By:
Pageof 380
Oncoimmunology|January 23, 2015
Breaking the vicious cycle between breast cancer cells and tumor-associated macrophagesShicheng Su, Wei Wu, Chonghua He, et al.Oncoimmunology|January 23, 2015
New insights into the mechanism of action of immune checkpoint antibodiesAurélien Marabelle, Holbrook Kohrt, Ronald LevyOncoimmunology|May 17, 2023
Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 statusDavid Dora, Balazs Ligeti, Tamas Kovacs, et al.Oncoimmunology|May 19, 2023
Prevention and treatment of cancers by tumor antigen-expressing Staphylococcus epidermidisOliver Kepp, Laurence Zitvogel, Guido KroemerOncoimmunology|March 6, 2023
Ferroptosis: friend or foe in cancer immunotherapy?Robin Demuynck, Iuliia Efimova, Elena Catanzaro, et al.Oncoimmunology|July 30, 2016
DC vaccine generated by ALA-PDT-induced immunogenic apoptotic cells for skin squamous cell carcinomaJie Ji, Yunfeng Zhang, Wei R Chen, et al.Oncoimmunology|July 30, 2016
Prioritization schema for immunotherapy clinical trials in glioblastomaTiffany R Hodges, Sherise D Ferguson, Hillary G Caruso, et al.Oncoimmunology|July 30, 2016
Intratumoral delivery of mTORC2-deficient dendritic cells inhibits B16 melanoma growth by promoting CD8(+) effector T cell responsesDàlia Raïch-Regué, Kellsye P Fabian, Alicia R Watson, et al.Oncoimmunology|July 30, 2016
NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8(+) T lymphocytesGalaxia M Rodriguez, Diwakar Bobbala, Daniel Serrano, et al.Oncoimmunology|July 30, 2016
miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancerLeonie Mühlberg, Benjamin Kühnemuth, Eithne Costello, et al.Pageof 380